Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17714
Country/Region: South Sudan
Year: 2017
Main Partner: Johns Hopkins University
Main Partner Program: JHPIEGO
Organizational Type: University
Funding Agency: USAID
Total Funding: $1,462,240 Additional Pipeline Funding: $331,797

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $8,725
Care: Pediatric Care and Support (PDCS) $95,979
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Prevention: HIV Testing and Counseling (HVCT) $587,494
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $350,291
Treatment: Adult Treatment (HTXS) $388,791
Treatment: Pediatric Treatment (PDTX) $30,960
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTC_TST_DSD By Test Result: Positive 2018 1,777
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 57,566
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Negative 2018 33
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Positive 2018 1
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 373
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 6
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 238
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 3
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 3
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 2
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: Unknown Age, Female, Negative 2018 10
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: Unknown Age, Male, Negative 2018 6
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 13,513
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 363
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) ANC: <15, Negative 2018 2,567
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) ANC: <15, Positive 2018 51
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 3,724
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 158
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 399
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 11
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 51
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 1
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 7
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 3,032
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 98
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 2,069
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 65
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 55
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 2
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 38
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 1
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 377
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 14
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 252
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 9
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative 2018 8
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: <15, Male, Negative 2018 4
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 16,002
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 580
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 10,669
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 386
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 327
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Positive 2018 10
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 218
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Positive 2018 6
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Negative 2018 917
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Positive 2018 34
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Negative 2018 611
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Positive 2018 22
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: <15, Female, Negative 2018 19
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: <15, Female, Positive 2018 1
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: <15, Male, Negative 2018 13
HTC_TST_DSD Sum of Test Result disaggregates 2018 1,777
PMTCT_ART_DSD Already on ART at beginning of current pregnancy 2018 233
PMTCT_ART_DSD New on ART 2018 386
PMTCT_ART_DSD Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 619
PMTCT_ART_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 16,466
PMTCT_EID_DSD Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 243
PMTCT_EID_DSD Number of infants with a negative virological test result between 2 and 12 months of birth 2018 63
PMTCT_EID_DSD Number of infants with a negative virological test result within 2 months of birth 2018 64
PMTCT_EID_DSD Number of infants with a positive virological test result between 2 and 12 months of birth 2018 1
PMTCT_EID_DSD Number of infants with a positive virological test result within 2 months of birth 2018 2
PMTCT_EID_DSD Unknown, 2 - 12 months 2018 54
PMTCT_EID_DSD Unknown, <= 2 months 2018 59
PMTCT_STAT_DSD By Age (Denominator): 10-14 2018 969
PMTCT_STAT_DSD By Age (Denominator): 20-24 2018 5,876
PMTCT_STAT_DSD By Age (Denominator): 25-49 2018 5,876
PMTCT_STAT_DSD By Age (Denominator): 50+ 2018 1,938
PMTCT_STAT_DSD By Age (Denominator): <10 2018 2,339
PMTCT_STAT_DSD By Age (Denominator): <15-19 2018 3,178
PMTCT_STAT_DSD By Age (Denominator): Unknown Age 2018 290
PMTCT_STAT_DSD By Age (Numerator): 10-14 2018 671
PMTCT_STAT_DSD By Age (Numerator): 15-19 2018 2,539
PMTCT_STAT_DSD By Age (Numerator): 20-24 2018 4,885
PMTCT_STAT_DSD By Age (Numerator): 25-49 2018 4,885
PMTCT_STAT_DSD By Age (Numerator): 50+ 2018 1,507
PMTCT_STAT_DSD By Age (Numerator): <10 2018 1,797
PMTCT_STAT_DSD By Age (Numerator): Unknown Age 2018 182
PMTCT_STAT_DSD By Number of known positives: 10-14 2018 2
PMTCT_STAT_DSD By Number of known positives: 15-19 2018 44
PMTCT_STAT_DSD By Number of known positives: 20-24 2018 82
PMTCT_STAT_DSD By Number of known positives: 25-49 2018 81
PMTCT_STAT_DSD By Number of known positives: 50+ 2018 34
PMTCT_STAT_DSD By Number of known positives: <10 2018 14
PMTCT_STAT_DSD By Number of known positives: Unknown Age 2018 5
PMTCT_STAT_DSD By Number of new negative: 10-14 2018 654
PMTCT_STAT_DSD By Number of new negative: 15-19 2018 2,436
PMTCT_STAT_DSD By Number of new negative: 20-24 2018 4,682
PMTCT_STAT_DSD By Number of new negative: 25-49 2018 4,682
PMTCT_STAT_DSD By Number of new negative: 50+ 2018 1,420
PMTCT_STAT_DSD By Number of new negative: <10 2018 1,754
PMTCT_STAT_DSD By Number of new negative: Unknown Age 2018 172
PMTCT_STAT_DSD By Number of new positives: 10-14 2018 16
PMTCT_STAT_DSD By Number of new positives: 15-19 2018 57
PMTCT_STAT_DSD By Number of new positives: 20-24 2018 121
PMTCT_STAT_DSD By Number of new positives: 25-49 2018 122
PMTCT_STAT_DSD By Number of new positives: 50+ 2018 49
PMTCT_STAT_DSD By Number of new positives: <10 2018 28
PMTCT_STAT_DSD By Number of new positives: Unknown Age 2018 11
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 16,466
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 97
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 92
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 64
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 61
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 161
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 153
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 752
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 720
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 195
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 171
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,305
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,269
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 335
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 293
TB_STAT_DSD Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 2,453
TB_STAT_DSD Total number of registered new and relapsed TB cases, during the reporting period 2018 2,587
TX_CURR_DSD Aggregated Age/Sex: 15+ Female 2018 887
TX_CURR_DSD Aggregated Age/Sex: 15+ Male 2018 786
TX_CURR_DSD Aggregated Age/Sex: <15 Female 2018 5
TX_CURR_DSD Aggregated Age/Sex: <15 Male 2018 4
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2018 1,682
TX_CURR_DSD Sum of Aggregated Age/Sex 15+ 2018 1,673
TX_CURR_DSD Sum of Aggregated Age/Sex <15 2018 9
TX_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2018 1,682
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Female 2018 633
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Male 2018 82
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Female 2018 2
TX_NEW_DSD Breastfeeding status 2018 130
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 717
TX_NEW_DSD Pregnancy status 2018 359
TX_NEW_DSD Sum of Aggregated Age/Sex disaggregates 2018 717
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 543
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 536
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 460
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 385
TX_RET_DSD Denominator by Status: Breastfeeding 2018 47
TX_RET_DSD Denominator by Status: Pregnant 2018 340
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 921
TX_RET_DSD Numerator by Status: Breastfeeding 2018 88
TX_RET_DSD Numerator by Status: Pregnant 2018 240
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 1,003
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Female 2018 20
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Male 2018 29
TX_TB_DSD Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 64
TX_TB_DSD Denominator: By Screen Result: Negative 2018 21
TX_TB_DSD Denominator: By Screen Result: Positive 2018 43
TX_TB_DSD Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 64
TX_TB_DSD Number of ART patients who were screened for TB at least once during the reporting period 2018 64
TX_TB_DSD Number of ART patients who were started on TB treatment during the reporting period 2018 43
TX_TB_DSD Numerator: By Aggregated Age/Sex: 15+, Female 2018 21
TX_TB_DSD Numerator: By Aggregated Age/Sex: 15+, Male 2018 22